Published by Josh White on 28th October 2025
(Sharecast News) - Novartis shares were sliding on Tuesday morning, after it reported solid third-quarter revenue growth but missed earnings expectations as the loss of patent protection for its blockbuster heart drug Entresto weighed on margins.
URL: http://www.digitallook.com/dl/news/story/35453094/...